ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,963.53
-0.13%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.727
0.21%
Brent Oil
84.055
0.13%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. AMEX
  6. Palatin Technologies Inc New (PTN)

  7. Palatin Technologies Inc New (PTN) ニュース

PTN

Palatin Technologies (PTN)

Palatin Technologies Inc New
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:PTN
日付受信時刻ニュースソース見出しコード企業名
2024/05/0920 : 30PR Newswire (US)Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024AMEX:PTNPalatin Technologies Inc New
2024/05/0220 : 30PR Newswire (US)Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of ObesityAMEX:PTNPalatin Technologies Inc New
2024/04/3020 : 30PR Newswire (US)Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024AMEX:PTNPalatin Technologies Inc New
2024/04/0820 : 30PR Newswire (US)Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024AMEX:PTNPalatin Technologies Inc New
2024/03/0807 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
2024/03/0502 : 57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
2024/02/2821 : 30PR Newswire (US)Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)AMEX:PTNPalatin Technologies Inc New
2024/02/1523 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
2024/02/1521 : 30PR Newswire (US)Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateAMEX:PTNPalatin Technologies Inc New
2024/02/1506 : 17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PTNPalatin Technologies Inc New
2024/02/1504 : 55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PTNPalatin Technologies Inc New
2024/02/0921 : 30PR Newswire (US)Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024AMEX:PTNPalatin Technologies Inc New
2024/02/0521 : 30PR Newswire (US)Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)AMEX:PTNPalatin Technologies Inc New
2024/02/0207 : 16Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
2024/02/0206 : 00PR Newswire (US)Palatin Announces Closing of $10 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
2024/02/0123 : 40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:PTNPalatin Technologies Inc New
2024/01/3022 : 00PR Newswire (US)Palatin Announces $10 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
2024/01/0900 : 33PR Newswire (US)Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024AMEX:PTNPalatin Technologies Inc New
2024/01/0322 : 00Business WireCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.AMEX:PTNPalatin Technologies Inc New
2023/12/2023 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
2023/12/2021 : 30PR Newswire (US)Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 MillionAMEX:PTNPalatin Technologies Inc New
2023/12/1906 : 45Edgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
2023/12/1906 : 15PR Newswire (US)Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE AmericanAMEX:PTNPalatin Technologies Inc New
2023/12/1814 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:PTNPalatin Technologies Inc New
2023/12/1606 : 03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PTNPalatin Technologies Inc New
2023/12/0907 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
2023/12/0707 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
2023/12/0704 : 25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
2023/12/0507 : 00Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:PTNPalatin Technologies Inc New
2023/12/0205 : 52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
 Showing the most relevant articles for your search:AMEX:PTN

最近閲覧した銘柄

CCOM
US100
US Tech 100
CCOM
US30
US 30
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
ETHUSD
Ethereum
USOTC
ADDYY
Adidas (QX)
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
CCOM
SILVER
SILVER
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有